Literature DB >> 3140779

Purification of low density lipoprotein receptor from liver and its quantification by anti-receptor monoclonal antibodies.

E Gherardi1, N Brugni, D E Bowyer.   

Abstract

The low density lipoprotein (LDL) receptor has been purified to homogeneity from rabbit liver by a combination of DEAE-Sephacel chromatography, LDL-Sepharose 4B chromatography and preparative SDS/polyacrylamide-gel electrophoresis. The receptor protein had a pI of 4.45 and an Mr of 120 x 10(3)-125 x 10(3) in SDS gels under non-reducing conditions. Incubation of the LDL receptor with neuraminidase decreased its Mr to 105 x 10(3)-110 x 10(3) and increased its pI from 4.45 to 5.25. The purified receptor exhibited all the properties of the membrane-bound receptor including Ca2+-dependent binding of rabbit and human LDL but not of methylated LDL or high density lipoprotein. The amount of LDL receptor present in rabbit liver was measured by a quantitative blotting procedure employing a newly developed rat anti-receptor monoclonal antibody. The affinity and specificity of this monoclonal antibody allowed the quantification of the LDL receptor in detergent extracts of liver homogenate, thus eliminating the loss of receptor associated with the preparation of membrane fractions prior to receptor assay. Livers from adult female New Zealand White rabbits contained 149 +/- 13 ng of LDL receptor/mg of liver protein. Administration of pharmacological doses of 17 alpha-ethinyloestradiol raised the concentration of LDL receptor in liver to 312 +/- 25 ng/mg of liver protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140779      PMCID: PMC1149314          DOI: 10.1042/bj2530409

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Receptor-mediated uptake of lipoprotein-cholesterol and its utilization for steroid synthesis in the adrenal cortex.

Authors:  M S Brown; P T Kovanen; J L Goldstein
Journal:  Recent Prog Horm Res       Date:  1979

2.  Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol.

Authors:  P T Kovanen; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

3.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.

Authors:  K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

4.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

5.  Tissue sites of degradation of low density lipoprotein: application of a method for determining the fate of plasma proteins.

Authors:  R C Pittman; A D Attie; T E Carew; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

6.  Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG.

Authors:  G Galfrè; C Milstein; B Wright
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

7.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

8.  Characterization of the estrogen-induced lipoprotein receptor of rat liver.

Authors:  A D Cooper; R Nutik; J Chen
Journal:  J Lipid Res       Date:  1987-01       Impact factor: 5.922

9.  Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit.

Authors:  H R Slater; C J Packard; S Bicker; J Shepherd
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

10.  Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys.

Authors:  R W Mahley; K H Weisgraber; G W Melchior; T L Innerarity; K S Holcombe
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

View more
  4 in total

1.  Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody.

Authors:  E Gherardi; D E Bowyer; C Fitzsimmons; T Le Cras; A Hutchings; G Butcher
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

2.  Transcriptional activation of low density lipoprotein receptor gene by angiotensin-converting enzyme inhibitors and Ca(2+)-channel blockers involves protein kinase C isoforms.

Authors:  L H Block; R Keul; M Crabos; R Ziesche; M Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

3.  Measurement of the absolute number of functioning low-density lipoprotein receptors in vivo using a monoclonal antibody.

Authors:  C Fitzsimmons; R Bush; D Hele; C Godliman; E Gherardi; D E Bowyer
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

4.  Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor.

Authors:  L H Block; H Matthys; L R Emmons; A Perruchoud; P Erne; M Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.